U.S. Supreme Court Hears Arguments In FCA Dispute Over Overcharging Medicare

Mealey's (April 19, 2023, 9:55 AM EDT) -- WASHINGTON, D.C. — Whistleblowers in consolidated qui tam actions told the U.S. Supreme Court in April 18 oral arguments that the Seventh Circuit U.S. Court of Appeals erred in affirming judgments for pharmacies accused of fraudulently overcharging Medicare, Medicaid and the Federal Employee Health Benefits Program for prescription drugs in violation of the False Claims Act (FCA) because the court failed to consider the relevance of the pharmacies’ subjective beliefs regarding whether they were overcharging the government programs....